Skip to content

13F-HR filed by Trustees of Columbia University in the City of New York

Trustees of Columbia University in the City of New York filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-15, with 10 holding rows worth $631,499,956.

Accession
0000904454-25-000276
Filed
2025-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 10 entries on the cover page, a total value of $631,499,956 stated on the cover page (in dollars after the unit check, H1), rows summing to $631,499,956 with VALUE read as dollars as filed, 13F file number 028-20933. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS1,109,343$620,555,381dollars as filed
NU HLDGS LTDG6683N103ORD SHS CL A909,930$9,317,683dollars as filed
SURROZEN INC86889P208COMMON STOCK47,930$558,864dollars as filed
VIGIL NEUROSCIENCE INC92673K108COM192,973$343,492dollars as filed
Q32 BIO INC746964105Common Stock133,903$220,940dollars as filed
Xilio Therapeutics Inc.98422T100COM249,635$180,736dollars as filed
TENAYA THERAPEUTICS INC87990A106COM291,828$166,342dollars as filed
RAPT THERAPEUTICS INC75382E109COM73,383$89,527dollars as filed
VOR BIOPHARMA INC929033108COM91,910$65,991dollars as filed
SURROZEN INC86889P117*W EXP 08/01/20333,333$1,000dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000904454-25-000276this filing2025-05-15acceptance time not in the bulk data set